Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study.

Barbara N HardingBridget M WhitneyRobin M NanceHeidi M CraneGreer BurkholderRichard D MooreW Christopher MathewsJoseph J EronPeter W HuntPaul VolberdingBenigno RodriguezKenneth MayerMichael S SaagMari M KitahataSusan R HeckbertJoseph A C Delaney

Published in: BMJ open (2020)

These findings suggest INSTI use may increase the risk of anaemia. If confirmed, screening for anaemia development in users of INSTIs may be beneficial. Further research into the underlying mechanisms is warranted.

Keyphrases

iron deficiency
hiv infected
human immunodeficiency virus
hiv aids
hiv positive
emergency department
adverse drug
hepatitis c virus